We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
45 hedge funds and large institutions have $61.8M invested in Larimar Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
3.9% more ownership
Funds ownership: 82.26% → 86.15% (+3.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 49 → 45 (-4)
61% less capital invested
Capital invested by funds: $157M → $61.8M (-$95.4M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
14
Reduced
11
Closed
6
Calls
$282K
Puts
–
Net Calls
+$282K
Net Calls Change
+$282K
Top Buyers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$4.11M |
| 2 |
Morgan Stanley
New York
|
+$3.39M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$2.03M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.24M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$393K |
Top Sellers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.31M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.13M |
| 3 |
FAM
Fred Alger Management
New York
|
-$1.9M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$818K |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$345K |
